{
  "id": 6266179,
  "title": "#ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer",
  "url": "https://urgent.news/2026/09/08/ers26-roivant-reports-phase-2-win-for-lung-disease-drug-that-it-got",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-08T10:00:00.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/ers26-roivant-reports-phase-2-win-for-lung-disease-drug-that-it-got-from-bayer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Roivant Sciences said Tuesday its inhaled drug candidate has passed a mid-stage test in interstitial lung disease, surpassing Wall Street’s benchmarks for success. In the Phase 2 trial, mosliciguat met the primary endpoint of change ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}